119 related articles for article (PubMed ID: 1358156)
1. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.
Wilson GD; Camplejohn RS; Martindale CA; Brock A; Lane DP; Barnes DM
Eur J Cancer; 1992; 28A(12):2010-7. PubMed ID: 1358156
[TBL] [Abstract][Full Text] [Related]
2. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
3. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
4. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis.
Woods AL; Hall PA; Shepherd NA; Hanby AM; Waseem NH; Lane DP; Levison DA
Histopathology; 1991 Jul; 19(1):21-7. PubMed ID: 1680784
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
6. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.
Landberg G; Roos G
Cancer Res; 1991 Sep; 51(17):4570-4. PubMed ID: 1678682
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it.
Sasaki K; Kurose A; Ishida Y
Cytometry; 1993 Nov; 14(8):876-82. PubMed ID: 7904555
[TBL] [Abstract][Full Text] [Related]
9. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
11. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
12. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
Teague K; el-Naggar A
Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
[TBL] [Abstract][Full Text] [Related]
13. Identification of S-phase cells with PC10 antibody to proliferating cell nuclear antigen (PCNA) by flow cytometric analysis.
Beppu T; Ishida Y; Arai H; Wada T; Uesugi N; Sasaki K
J Histochem Cytochem; 1994 Aug; 42(8):1177-82. PubMed ID: 7913107
[TBL] [Abstract][Full Text] [Related]
14. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
Diebold J; Lai MD; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
[TBL] [Abstract][Full Text] [Related]
15. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
Camplejohn RS; Brock A; Barnes DM; Gillett C; Raikundalia B; Kreipe H; Parwaresch MR
Br J Cancer; 1993 Apr; 67(4):657-62. PubMed ID: 7682430
[TBL] [Abstract][Full Text] [Related]
16. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
Lohr F; Wenz F; Haas S; Flentje M
Cell Prolif; 1995 Feb; 28(2):93-104. PubMed ID: 7893842
[TBL] [Abstract][Full Text] [Related]
17. PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues. A combined immunocytochemical and flow cytometric study.
Casasco A; Giordano M; Danova M; Casasco M; Icaro Cornaglia A; Calligaro A
Histochemistry; 1993 Mar; 99(3):191-9. PubMed ID: 7684034
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
Pich A; Chiusa L; Comino A; Navone R
Virchows Arch; 1994; 424(2):143-8. PubMed ID: 7910097
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]